Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07770425 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07770425 · ClinicalTrials.gov record · last posted 2026-08-18

Lesion Size Measurement During Gastrointestinal Endoscopies

Study acronym: AccuMeasure
StatusRecruiting
PhaseNot specified
Started2025-05-09
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The goal of this prospective observational study is to assess the accuracy and reliability of laser readings obtained through AccuMeasure, in comparison to other measurements performed by gastroenterologists. AccuMeasure is a novel technology, that has emerged as a promising tool for measuring polyps and lesions during colonoscopies. The system employs laser-based measurements, enabling precise determination of lesion size, depth, and extent. The main hypotheses this study aims to evaluate are: * AccuMeasure technology, with its precise laser measurements, will demonstrate superior accuracy and reliability in assessing lesion size of pathologies encountered during endoscopies, when compared to other endoscopic scoring methods. * AccuMeasure measurements will show strong construct validity by correlating significantly with endoscopic subscores, symptomatic remission (CD PRO2 \<8, partial mayo score), and fecal calprotectin values.
Trial Details
NCT Number NCT07770425
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Conditions Polyp of Colon, Crohn Disease
Enrollment 3,000 participants
Start Date 2025-05-09
Primary Completion 2027-05 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-18